Quantcast

Latest Stem cell treatments Stories

2014-05-27 16:25:18

NEW YORK, May 27, 2014 /PRNewswire/ -- Brian Mehling, M.D., an American orthopedic trauma surgeon, founder, and chief medical officer of Blue Horizon International (BHI) and Blue Horizon Charitable Foundation (BHCF), visited with orphaned children on a recent business trip to Abuja and Lagos in Nigeria. After touring the facility, meeting with the founder, and her staff, he also made a $1,000 donation to help the orphanage fulfill its vision to provide shelter for abandoned and...

2014-05-27 12:33:02

Americord Yields 60% More CD34+ Stem Cells, 54% More Cord Blood, and 34% Higher TNC Than Competitors NEW YORK, May 27, 2014 /PRNewswire/ -- Americord announced today that its cord blood stem cell collection statistics beat the cord blood banking industry averages by significant margins across three critical measures. An in-depth analysis of collection samples through March 31, 2014 revealed that Americord collects 60% more CD34+ stem cells, 54% higher volume, and 34% higher total...

2014-05-26 12:23:17

MUMBAI, May 26, 2014 /PRNewswire/ -- Dominate the Stem Cell Product Market by Making Smarter Decisions Faster Stem cells are still a relatively new discovery, as the first mouse embryonic stem cells were derived from embryos in 1981, but it was not until 1995 that the first successful culturing of embryonic stem cells from non-human primates occurred and not until 1998 when a technique was developed to isolate and grow embryonic stem cells from human blastocysts. Soon...

2014-05-23 12:24:31

GERMANTOWN, Md., May 23, 2014 /PRNewswire/ -- Neuralstem, Inc. (NYSE MKT: CUR) announced that data from the NSI-189 Phase Ib study in major depressive disorder (MDD) will be presented at the American Society of Clinical Psychopharmacology Annual Meeting in Hollywood, Florida, on June 17th at 4:15 EDT. NSI-189 is Neuralstem's first-in-class, lead neurogenic small molecule compound. In pre-clinical studies, NSI-189 was shown to promote the formation of new neurons (neurogenesis) in...

2014-05-22 23:01:07

Cellular therapy procedure can have miraculous results on people suffering from chronic back pain or disc degeneration in particular - as was proven in the case of Beth, a 28-year old patient at MetroMD in Los Angeles diagnosed with degenerative disc disease (DDD). Los Angeles, CA (PRWEB) May 22, 2014 According to MetroMD Institute of Regenerative Medicine, cellular therapy procedures can have miraculous results on people suffering from chronic back pain or disc degeneration in particular...

2014-05-22 10:32:28

University of Cambridge A new method of generating mature nerve cells from skin cells could greatly enhance understanding of neurodegenerative diseases, and could accelerate the development of new drugs and stem cell-based regenerative medicine. The nerve cells generated by this new method show the same functional characteristics as the mature cells found in the body, making them much better models for the study of age-related diseases such as Parkinson's and Alzheimer's, and for the...

2014-05-20 23:07:28

Okyanos Heart Institute Announces Addition of Adipose Stem Cell Research Pioneer to Okyanos’ Cardiac Cell Therapy Medical Team Freeport, The Bahamas (PRWEB) May 20, 2014 Okyanos Heart Institute has announced the addition of Dr. Todd Malan to their executive medical team as Chief Cell Therapy Officer and General Surgeon. He will perform and oversee the liposuction step of Okyanos treatment, removing a small amount of fat from patients from which their own stem cells are isolated. Cardiac...

2014-05-20 16:25:34

HACKENSACK, N.J., May 20, 2014 /PRNewswire/ -- Long Islander Greg Mucci participated in sports his whole life until a motorcycle accident in 2004. Unfortunately, his injury developed into avascular necrosis and sidelined his hopes for a pro athletic career. Mr. Mucci, 30, credits his steady recovery to Brian Mehling, M.D. and support from Dr. Mehling's Blue Horizon charities. Today, he works as a Licensed Practical Nurse (LPN). At 6'2" and 230 pounds he has returned to bodybuilding,...

2014-05-16 08:27:03

/PRNewswire/ -- Neuralstem, Inc. (NYSE MKT: CUR) CEO and President, Richard Garr, will present at the World Stem Cells & Regenerative Medicine Congress, on Thursday, May 22, at 11:35 a.m. BST in London, UK (http://www.terrapinn.com/conference/stem-cells/index.stm). Neuralstem is currently in a Phase II clinical trial to treat ALS (Amyotrophic Lateral Sclerosis, or Lou Gehrig's disease) with its NSI-566 stem cells and has been approved to commence a Phase I study in spinal cord...

2014-05-15 23:06:12

Local Stem Cell Clinic Celebrates Anniversary with Hundreds of Patients Treated Tampa, Florida (PRWEB) May 15, 2014 On Tuesday, May 20, Lung Institute is celebrating the first anniversary of its Tampa location. As a leader in regenerative medicine, Lung Institute has provided over 250 treatments to lung disease patients who previously had no hope for better breathing and regaining quality of life. Lung Institute treats lung diseases including pulmonary fibrosis and chronic obstructive...


Word of the Day
malpais
  • The ragged surface of a lava-flow.
'Malpais' translates from Spanish as 'bad land.'